HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Acetylcholinesterase Inhibitor

Acetylcholinesterase Inhibitor

Acetylcholinesterase Inhibitors are drugs which limit the activity of the enzyme acetylcholinesterase. Acetylcholinesterase (AChE) is an enzyme which breaks down the neurotransmitter acetylcholine (ACh) into its component parts. AChE inhibitors therefore increase the amount of ACh in the synapse, the area between brain cells where information is transmitted, and interact with a variety of receptors including cholinergic nicotinic receptors. This activity means AChE inhibitors can have a wide range of therapeutic effects. There are several medical uses for AChE inhibitors. The most well-known is in the treatment of Alzheimer's disease, where it is believed that reducing AChE activity helps prevent the breakdown of ACh, leading to increased activity in the hippocampus. In addition, AChE inhibitors have been studied in the treatment of Parkinson's disease, schizophrenia, chronic pain, and depression and may help improve cognitive function in patients with dementia. AChE inhibitors also have other non-medical applications. They are used as organophosphate pesticides, such as malathion, to control insects. Additionally, during dietary changes or fasting periods, AChE inhibitors can cause a stimulation of the ingestion of food due to increased activity in the areas of the brain responsible for hunger. The effects of AChE inhibitors may vary depending on the individual. Common side effects may include nausea, vomiting, diarrhoea, increased salivation, muscle weakness, tremors, dizziness, headache, and confusion. Rarely, AChE inhibitors can cause a decrease in white blood cells, leading to infection, or life-threatening breathing difficulties. Therefore, it is important to consult with a doctor or pharmacist if any of these symptoms occur. In conclusion, acetylcholinesterase inhibitors are useful drugs for a range of medical and non-medical applications. They can be helpful in reducing the degradation of acetylcholine and increasing synaptic activity, but they may also have side effects. Therefore, it is important that they be used with caution and only under the guidance of a medical professional.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
Tags

Submit your abstract Today

Watsapp